Latest debt-to-equity ratio
Compass Therapeutics Debt-to-equity ratio
Compass Therapeutics (CMPX) debt-to-equity ratio with its verified observation…
Direct answer
Compass Therapeutics's debt-to-equity ratio is 5.8%.
The verified market snapshot reports 5.8%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 1, 2026.
Get free Compass Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 5.8%
Explore related company data
View Compass Therapeutics's market capitalizationView Compass Therapeutics's price-to-book ratioView Compass Therapeutics's return on equityView Compass Therapeutics's 52-week price rangeView Compass Therapeutics's profit marginView all Compass Therapeutics key metricsReturn to Compass Therapeutics profile